China Just Reached Into Singapore and Took Back an AI Company Meta Had Already Bought
The deal was done. Manus had signed. Its founders and engineers had moved into Meta’s Singapore offices. The technology was being integrated into Meta AI’s product pipeline. Mark Zuckerberg had paid somewhere between $2 billion and $3 billion for an agentic AI company that had done everything right — built in China, yes, but then relocated to Singapore, reincorporated there, closed its Beijing offices, laid off its China-based employees — specifically to exist outside Beijing’s reach.
On April 27, 2026, China’s National Development and Reform Commission issued a statement. One sentence. No explanation. It had decided to prohibit foreign investment in Manus and was requiring both parties to unwind the transaction.
The legal mechanism behind that sentence is, to put it plainly, unclear. Manus is a Singapore company. Meta is an American company. China’s authority over transactions between Singapore and US entities is not established law. But the NDRC issued the order anyway, and the question for the rest of the AI industry is not whether Beijing has the legal right to do this — it’s whether anyone will meaningfully contest it.
Direct Answer: What happened with China blocking Meta’s Manus acquisition?
On April 27, 2026, China’s National Development and Reform Commission — the country’s top economic planning agency — ordered Meta to unwind its completed acquisition of Manus, an agentic AI startup. Meta had announced the deal in December 2025, paying approximately $2 to $3 billion for a company that had recently relocated its headquarters from Beijing to Singapore. Manus was founded in 2022 as Butterfly Effect by Hong, Ji, and Tao Zhang, and gained international attention in March 2025 when it launched a general-purpose AI agent capable of complex autonomous tasks — earning comparisons to DeepSeek for its capabilities. The NDRC’s one-line statement offered no legal reasoning, no grounds, and no timeline. It simply stated that it had decided to prohibit foreign investment in the Manus project in accordance with laws and regulations, and required both parties to withdraw the acquisition transaction. The intervention is one of China’s most significant exercises of foreign investment review authority and the first time Beijing has asserted jurisdiction over a deal between a Singapore entity and a US entity on the grounds that the Singapore entity’s origins are Chinese.
The Vucense AI Acquisition Sovereignty Risk Index
How the major AI talent corridors compare on sovereign acquisition risk — for investors and acquirers evaluating cross-border AI deals after the Manus ruling.
| Startup Origin | Relocation Jurisdiction | US Acquisition Risk | Chinese Veto Risk Post-Manus | Investor Assessment |
|---|---|---|---|---|
| China-founded, China-headquartered | China | High (CFIUS) | Certain | Avoid for US exit |
| China-founded, Singapore-relocated (Manus model) | Singapore | Moderate (CFIUS) | Now demonstrated | Risk profile fundamentally changed |
| China-founded, US-relocated | USA | Moderate (CFIUS) | Uncertain — untested | CFIUS scrutiny + now China veto risk |
| US-founded, US-headquartered | USA | Low | None | Clean acquisition path |
| EU-founded, EU-headquartered | EU | Low | None | Clean, EU AI Act compliance required |
| India-founded, Singapore/US-relocated | Various | Low–Moderate | None | Generally clean |
The Manus ruling fundamentally changes the risk profile for the “Singapore relocation” strategy that dozens of Chinese AI startups have pursued since 2024 to attract US venture capital and enable US acquisitions. The strategy now faces both CFIUS scrutiny on the US side and demonstrated Chinese veto authority on the China side.
Why Manus Moved to Singapore — and Why It Didn’t Work
Understanding the Manus situation requires understanding the playbook that dozens of Chinese AI startups have used since 2024.
US export controls on advanced chips made raising capital in the US difficult for Chinese-headquartered AI companies. US venture firms faced legal and reputational pressure to avoid investments that could indirectly support Chinese military applications. And US technology companies looking to acquire AI talent faced CFIUS — the Committee on Foreign Investment in the United States — which blocks acquisitions of Chinese companies on national security grounds.
The solution, for founders who wanted US capital and US exits, was Singapore. Reincorporate there. Move the headquarters. Close the China offices. Operate as a Singapore company. Under this structure, a US venture firm investing is not investing in a Chinese company — it’s investing in a Singapore company. A US acquirer buying is not acquiring a Chinese company — it’s acquiring a Singapore company.
Manus executed this strategy precisely. Butterfly Effect, the Beijing entity, was wound down. A Singapore entity was incorporated. US venture firm Benchmark led a $75 million funding round in April 2025. Meta came knocking later that year. From a formal legal standpoint, the Singapore relocation had worked exactly as designed.
Beijing’s probe started in January 2026, one month after Meta announced the deal. The NDRC had launched its investigation quietly, without announcement. The founders, investors, and acquirers spent four months uncertain about the outcome. Then, on April 27, the one-line statement arrived.
The legal theory China is apparently operating on is something like this: Manus may be incorporated in Singapore, but its technology, its intellectual property, and its founders were developed in China. That technology and those founders represent Chinese national assets — the product of Chinese education, Chinese research infrastructure, and Chinese market access. Relocating to Singapore does not transfer ownership of that developmental history. Beijing did not consent to the transfer of that national asset to a US company.
That theory does not have clear grounding in international law. It does not appear in the NDRC’s published foreign investment review regulations. And the one-line statement offered no reasoning that would allow anyone to evaluate what standard is being applied. But it’s the theory that is now implicit in China’s action, and it will reshape how every Chinese-founded AI startup calculates its options.
What Manus Actually Built — and Why Beijing Wanted It Back
It helps to understand what, specifically, China didn’t want Meta to have.
Manus is an agentic AI system. Not a chatbot. Not an image generator. An agent — a system that takes instructions in natural language and then goes away and executes complex, multi-step tasks on its own. In March 2025, when Manus released its first product, it demonstrated the system completing tasks like market research (gathering and synthesising information from dozens of sources), coding projects (writing and debugging functional software), and data analysis (processing and interpreting structured datasets).
For many in China, this was a moment of national pride comparable to DeepSeek’s January 2025 moment. A Chinese-born team had built something that demonstrated general-purpose agentic capability at a time when most Western labs were still treating agents as a research problem. The comparison to DeepSeek was everywhere on Chinese social media.
Then the Singapore relocation happened. Then Benchmark’s investment. Then the Meta acquisition. Chinese social media’s reaction shifted from pride to something considerably darker. Commenters called it “treacherous.” Some accused the founders of “selling out” to an adversary. The national pride that had surrounded Manus’s launch curdled into something that gave Beijing political cover — and arguably political pressure — to intervene.
Agentic AI is the capability that China’s government has singled out as strategically critical. The 2026–2030 five-year plan explicitly targets agentic systems. Beijing’s concern is not abstract. An AI agent that can autonomously execute market research, data analysis, coding, and complex multi-step workflows is not a consumer product. It is dual-use infrastructure. Meta getting that technology — and its underlying training data, architectural innovations, and team — is not just a business loss. From Beijing’s perspective, it is a transfer of strategic capability to an adversary.
The Precedent This Sets — and Who Should Be Worried
The Manus ruling is notable not for what it does to Meta but for what it signals to everyone else.
Benchmark is the immediate casualty. The US venture firm led Manus’s $75 million round in April 2025, valuing the company at the time at roughly $500 million. The Meta acquisition would have returned the investment several times over. Now Benchmark holds equity in a company whose acquisition has been unwound, whose US acquirer has walked away, and whose Singapore headquarters was the legal fiction that the deal required. Senator John Cornyn had already questioned whether American capital should flow to Chinese-linked firms. Benchmark’s Manus investment is now the poster child for exactly that concern.
Every “Singapore relocation” strategy is now in question. Lawyers advising Chinese AI startups on their international capital strategies have been getting phone calls since April 27. The conventional wisdom — incorporate in Singapore, raise US capital, exit to a US acquirer — has been the dominant playbook for Chinese AI founders with global ambitions since 2024. The Manus ruling has not made that playbook illegal. It has demonstrated that China considers itself entitled to veto the final step regardless of where the company is incorporated.
CFIUS now faces a mirrored problem. The United States screens inbound investments by foreign entities into US companies. China has now demonstrated that it screens outbound acquisitions of Chinese-origin entities by US companies. From a sovereignty standpoint, the global AI acquisition market is now caught between two regulatory veto systems — one US, one Chinese — that can each block the same transaction from opposite ends. A US company trying to acquire Chinese AI talent faces CFIUS scrutiny going in and NDRC scrutiny going out.
The AI nationalism trend is accelerating. In the same week that China blocked Meta’s Manus acquisition, France passed legislation requiring French AI companies to notify the government before accepting foreign acquisition offers above certain thresholds. The EU AI Act contains provisions for member states to review AI acquisitions on national security grounds. The UK’s National Security and Investment Act has been used to review and block AI-related acquisitions since 2022. The global AI acquisition market is fragmenting along national lines, and the Manus ruling is the most dramatic single example of that fragmentation yet.
What Happens Now
The immediate practical question is what “unwinding” actually means when the deal is already complete. Manus’s engineers are in Meta’s Singapore offices. The technology has been partially integrated. The founders’ equity has presumably been paid out.
CNBC’s report noted that it was not immediately clear on what grounds China was seeking the annulment of a deal involving a Singapore-based company and how, if at all, a completed acquisition transaction would be unwound. That legal uncertainty is itself the story. China has issued an order whose mechanism it has not explained, for a transaction it arguably has no formal jurisdiction over, without any legal process that the affected parties could participate in.
Meta has not publicly commented on what it intends to do. The company faces a genuine dilemma. Complying with the NDRC order means voluntarily unwinding a completed, legal transaction — a capitulation to Chinese regulatory authority that sets a precedent for every future deal involving Chinese-linked technology. Refusing to comply means that Manus’s founders and the integrated technology remain in a legal limbo, and that Meta’s operational presence in China — which still represents a meaningful advertising market — faces potential consequences.
The founders are in the most uncomfortable position. They relocated from China, closed their China offices, laid off their China-based employees, and structured everything specifically to operate outside Beijing’s jurisdiction. They sold to Meta in good faith under Singapore law. Now they are being ordered to undo that transaction by the government of a country they left.
Actionable Steps
For US venture firms with Chinese-founded portfolio companies: Run a portfolio audit this week. Every Chinese-founded company that has executed a Singapore relocation strategy needs to be evaluated for Manus-style NDRC exposure. The relevant question is not where the entity is incorporated but what proportion of the IP was developed in China and whether Chinese nationals on the founding team maintain PRC citizenship or significant China ties. Document these assessments now, before any acquisition process starts.
For US acquirers evaluating Chinese-founded AI targets: Build an explicit NDRC risk assessment into your deal process for any target with Chinese origins, regardless of its current headquarters jurisdiction. The Manus precedent means the risk is no longer theoretical. Structure deals with unwinding provisions that contemplate Chinese regulatory intervention and allocate that risk explicitly between buyer and seller.
For Chinese AI founders planning international strategies: The Singapore relocation strategy has not been made impossible by this ruling — but it now comes with demonstrated tail risk that any subsequent M&A transaction may face Chinese veto. Founders considering this path need legal advice from counsel who understand both Chinese foreign investment law and the NDRC’s novel jurisdictional theory implicit in the Manus ruling. Document every aspect of the IP development history and be prepared to engage with Beijing’s review process explicitly rather than hoping to sidestep it.
For AI policy researchers and practitioners: The Manus ruling is the most concrete example yet of AI capability being treated as national patrimony rather than commercially transferable property. Track the legal proceedings around the unwinding — if there are any — for the jurisdictional theory that emerges. It will define the next several years of cross-border AI M&A.
FAQ: China, Meta, Manus, and What It Means
Q: How can China block a deal between a Singapore company and a US company? China has not publicly explained its legal theory. The NDRC’s statement referenced “laws and regulations” without specifying which. The implicit theory appears to be that because Manus was founded in China, its technology and founders constitute Chinese national assets subject to Chinese oversight regardless of the company’s current incorporation. This theory does not have clear grounding in established international law, which is why multiple legal experts cited in coverage noted that the mechanism for unwinding the deal is unclear.
Q: Does Meta have to comply with the NDRC order? Meta has not publicly responded. Technically, a US company is not automatically subject to Chinese regulatory orders covering transactions between third-country entities. However, China is a significant market for Meta’s advertising business, and non-compliance carries the risk of regulatory retaliation in that market. Meta’s practical calculus involves weighing the value of the Manus acquisition against the cost of Beijing’s displeasure — a calculation the company had not expected to face when it structured a Singapore-to-US deal.
Q: What is an AI agent and why is it strategically significant? An AI agent is a system that receives a goal in natural language and autonomously executes a series of steps to achieve it, without continuous human instruction. Unlike a chatbot that answers questions, an agent takes actions — searching the web, writing and running code, analysing data, completing forms, making API calls. Agentic AI is what transforms AI from a productivity tool into an autonomous workforce. That’s why governments treat it as strategically significant: an AI agent that can autonomously execute complex tasks represents a dual-use capability with direct applications in intelligence, logistics, economic analysis, and cyberoperations.
Q: What is the NDRC and what authority does it have? The National Development and Reform Commission is China’s top economic planning agency. Among its functions is a foreign investment review process established under China’s 2019 Foreign Investment Law. That process is generally understood to apply to foreign investment in Chinese entities — not to foreign acquisitions of non-Chinese entities with Chinese founders. The Manus ruling appears to be applying that authority in a novel way that has no clear precedent.
Q: Will other Chinese-founded AI startups face the same risk? The Manus ruling implies that any AI startup with Chinese origins — regardless of its current jurisdiction — may face Chinese veto power over future acquisition transactions. The immediate candidates are other Chinese-founded companies that have executed Singapore or US relocations to attract Western capital. The ruling has not made this universal policy, but it has demonstrated capability and willingness that every Chinese-founded startup’s legal counsel must now account for.
Q: What happened to Manus’s China-based employees? When Manus raised Benchmark’s $75 million round in April 2025 and began its Singapore transition, the company shut its China offices and laid off dozens of employees. Those individuals are not part of the Singapore entity that Meta acquired. The founders and core technical team had relocated to Singapore. The unwinding of the acquisition does not restore the China offices or the laid-off employees.
Related Articles
- DeepSeek Just Ended Its Independence — and Jensen Huang Is Worried
- China’s Robot Just Beat the Human World Record — Now It’s Coming for Your Workplace
- Cohere Just Bought Europe’s AI Champion — and Declared War on OpenAI
- Best Open-Source AI Models in April 2026 — Ranked by Sovereignty
- Anthropic Just Took $100 Billion From Its Three Biggest Competitors
